s**u
发帖数: 9035 | 1 博士后回国不要妄自菲薄，要抗争。两个例子。
复旦物理系主任以前在像树岭国家实验室(TN State）是research scientist, 2006年
海归浙江大学，2010年是复旦物理系主任,千人计划。
复旦药学院院长以前在新加坡国立大学作药理学postdoc, 2005年海归后担任药学院特
聘教授，院长至今。
很多博士后回国自己瞧不起自己，与用人单位谈判时候，自我砍价。结果被用人单位瞧
不起，许多国外的faculty连复旦的Job offer也拿不到。或者只拿到普通的教职。
上述两人凭着顽强的毅力，不屈不挠的抗争，终于赢得社会地位和较好的待遇。 | C*******e
发帖数: 4348 | | n***8
发帖数: 634 | 3 Time makes big difference.
In the game of matching resident MD, 10 years ago, those graduate more than 20 years, with
low scores, could get 10+ IVs.
Nowadays, those graduate less than 10 years, top scores, could get less than
10 IVs.
【在 s**u 的大作中提到】
: 博士后回国不要妄自菲薄，要抗争。两个例子。
: 复旦物理系主任以前在像树岭国家实验室(TN State）是research scientist, 2006年
: 海归浙江大学，2010年是复旦物理系主任,千人计划。
: 复旦药学院院长以前在新加坡国立大学作药理学postdoc, 2005年海归后担任药学院特
: 聘教授，院长至今。
: 很多博士后回国自己瞧不起自己，与用人单位谈判时候，自我砍价。结果被用人单位瞧
: 不起，许多国外的faculty连复旦的Job offer也拿不到。或者只拿到普通的教职。
: 上述两人凭着顽强的毅力，不屈不挠的抗争，终于赢得社会地位和较好的待遇。
| B**********s
发帖数: 1520 | 4 05 06年千老搞个985正叫兽很轻松
你现在去试试 | Z*I
发帖数: 397 | 5 沈健2003年拿了US Presidential Early Career Award for Science and Engineering
(PECASE)
你去看看拿PECASE的条件
他在Oak Ridge National laboratory早就是permanent member了
就凭PECASE他如果在学术界也肯定tenure的
你认为他是postdoc这个级别的？
朱依谆2005年回国的时候是associate professor
新加坡学术界和美国制度不一样，没有tenure track
他90篇journal paper，1120个citation，也是很好的成绩
之后拿了973首席科学家也证明复旦没选错人，一个学校能拿973首席科学家的有几个人？
Prof. Zhu got his Bachelor of Medicine (M.B.B.S.) from Shanghai Second
Medical University in 1989 and Dr. med. (M.D./Ph.D.) at Dept. of Internal
Medicine, University of Heidelberg, Germany in 1995. He did postdoctoral
training and later as project leader at German Institute of Hypertension
Research, and Institute of Pharmacology, University of Kiel, Germany and
worked also in University of Washington as a visiting scholar. Before he
moved to Singapore in 1998, he worked as Regional Scientific Manager (
Cardiovascular drugs), Hoechst Marion Roussel Pharma AG (now Sanofil-Aventis
). He moved to National University of Singapore (NUS) in 1998 and worked as
Lee Kuan Yew Research Fellow/Principal Investigator and late as Associate
Professor at the Dept. of Pharmacology, NUS. In 2005, Prof. Zhu was
appointed as Dean of School of Pharmacy and Director, Institute of Drug R&D,
Fudan University. Prof. Zhu published more than 90 SCI papers with more
than 1120 citations and edited 2 books for the natural products research and
received good recognition in this area. He is an editor and reviewer for
several international scientific journals. Meanwhile, he serves also as
External Expert/evaluator for Centre of drug evaluation, HSA (Singapore) and
SFDA (China). He holds several US, China patents for the drug discovery and
extensively involved for drug R&D. One cardioprotective drug has been
successfully launched in Singapore. Dr. Zhu was awarded National
Distinguished Young Scientists Grant in 2008 and National Chief Scientist
for 973 project and National Drug Discovery platform in 2009.
【在 s**u 的大作中提到】
: 博士后回国不要妄自菲薄，要抗争。两个例子。
: 复旦物理系主任以前在像树岭国家实验室(TN State）是research scientist, 2006年
: 海归浙江大学，2010年是复旦物理系主任,千人计划。
: 复旦药学院院长以前在新加坡国立大学作药理学postdoc, 2005年海归后担任药学院特
: 聘教授，院长至今。
: 很多博士后回国自己瞧不起自己，与用人单位谈判时候，自我砍价。结果被用人单位瞧
: 不起，许多国外的faculty连复旦的Job offer也拿不到。或者只拿到普通的教职。
: 上述两人凭着顽强的毅力，不屈不挠的抗争，终于赢得社会地位和较好的待遇。
| U**D
发帖数: 102 | 6 具体情况要具体分析！
【在 s**u 的大作中提到】
: 博士后回国不要妄自菲薄，要抗争。两个例子。
: 复旦物理系主任以前在像树岭国家实验室(TN State）是research scientist, 2006年
: 海归浙江大学，2010年是复旦物理系主任,千人计划。
: 复旦药学院院长以前在新加坡国立大学作药理学postdoc, 2005年海归后担任药学院特
: 聘教授，院长至今。
: 很多博士后回国自己瞧不起自己，与用人单位谈判时候，自我砍价。结果被用人单位瞧
: 不起，许多国外的faculty连复旦的Job offer也拿不到。或者只拿到普通的教职。
: 上述两人凭着顽强的毅力，不屈不挠的抗争，终于赢得社会地位和较好的待遇。
| s**u
发帖数: 9035 | 7 It's true, and that's a problem for China to recruit young and promising
researchers from overseas. For those individuals with no special
connection, given the reality in China, the best strategy is to stay
overseas, get recognized, and then return. If they return immediately with a
fresh PhD or postdoc experience, they may get a miserable offer (and then
a miserable life). Actually it doesn't make any sense at all for them,
because
they may get a good research position in the US and the pay is 10-15 times
higher. |
|
